Show simple item record

dc.contributor.authorBaz, D.
dc.contributor.authorMurakami, S.
dc.contributor.authorYokoi, T.
dc.contributor.authorLee, K. H.
dc.contributor.authorDe Wit, M.
dc.contributor.authorCho, B. Chul
dc.contributor.authorGray, J.
dc.contributor.authorRyden, A.
dc.contributor.authorViviers, L.
dc.contributor.authorPoole, L.
dc.contributor.authorDennis, P.
dc.contributor.authorAntonia, S.
dc.contributor.authorOzguroglu, M.
dc.contributor.authorHui, R.
dc.contributor.authorDaniel, D.
dc.contributor.authorChiappori, A.
dc.date.accessioned2021-03-02T23:15:06Z
dc.date.available2021-03-02T23:15:06Z
dc.date.issued2017
dc.identifier.citationHui R., Ozguroglu M., Daniel D., Baz D., Murakami S., Yokoi T., Chiappori A., Lee K. H. , De Wit M., Cho B. C. , et al., "Patient-Reported Outcomes with Durvalumab after Chemoradiation in Locally Advanced, Unresectable NSCLC: Data from PACIFIC", JOURNAL OF THORACIC ONCOLOGY, cilt.12, sa.11, 2017
dc.identifier.issn1556-0864
dc.identifier.othervv_1032021
dc.identifier.otherav_115a4005-3bc1-432e-9514-a092f1574de6
dc.identifier.urihttp://hdl.handle.net/20.500.12627/17154
dc.identifier.urihttps://doi.org/10.1016/j.jtho.2017.09.096
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectSOLUNUM SİSTEMİ
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectGöğüs Hastalıkları ve Allerji
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.titlePatient-Reported Outcomes with Durvalumab after Chemoradiation in Locally Advanced, Unresectable NSCLC: Data from PACIFIC
dc.typeMakale
dc.relation.journalJOURNAL OF THORACIC ONCOLOGY
dc.contributor.departmentUniversity Of Sydney , ,
dc.identifier.volume12
dc.identifier.issue11
dc.contributor.firstauthorID247531


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record